|Day Low/High||209.48 / 219.15|
|52 Wk Low/High||148.65 / 222.82|
What if everyone believes in free trade, but not everyone harbors the same understanding of the term?
Jim Cramer says you shouldn't dismiss the FANG stocks, despite controversy, uncertainty, rate hikes or even earnings. It's about the future.
Program ready for 2018 GPS III launch, on-orbit testing
Raytheon technology fills in gaps in long-range fires and short-range air defense
We are still looking for opportunities where we can prune positions to raise funds when appropriate.
Notable weakness is coming from the FANG leadership group, which is being weighed down by heavy losses in Facebook.
Unease permeates the stock market. From regulatory rulings to blocked mergers, the attitude from -- and about -- Washington is very different this year.
We're violating our basis, but that's because we initiated our stake at extremely low levels.
Jim Cramer focuses on Merck, Eli Lilly, Abbott Labs, Phillips 66, Five Below, and Cintas in the Lightning Round.
Do we trade on the news out of Washington? Jim Cramer talks about Larry Kudlow and his stand on economic growth.
Strategic investing should not rely upon the whims of a politically volatile environment.
U.S. regulators are reviewing the proposed merger between the two media companies.
Rex Tillerson will be replaced by CIA Director Mike Pompeo.
Most of all, we have all learned that, no..... it doesn't come easy.
Standard Terminal Automation Replacement System ready for NextGen Air Traffic Control
Investment by 14 Patriot partner nations make new technology upgrades possible
Worry abounds on Wall Street this week. Do you know which stocks have the lowest exposure to developments from Washington?
Jim discusses Comcast's bid for Sky, Broadcom, Fed Chair Powell's testimony and more.
Survey findings come after unanimous intelligence community warning about growing cyber threat
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.